Bacteria and coronary atheroma: More fingerprints but no smoking gun

Circulation

Volumn 113, Issue 7, 2006, Pages 920-922

  Katz, Joel T ^a   Shannon, Richard P ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; ATHEROMA; CELL WALL; CHLAMYDIA; EDITORIAL; ENDOTHELIUM CELL; HUMAN; IMMUNE SYSTEM; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; BACTERIAL INFECTION; BACTERIUM; CORONARY ARTERY ATHEROSCLEROSIS; IMMUNITY; IMMUNOLOGY; INFLAMMATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE; RISK FACTOR;

BACTERIA; BACTERIAL INFECTIONS; CORONARY ARTERIOSCLEROSIS; HUMANS; IMMUNITY; INFLAMMATION; RISK FACTORS;

EID: 33645053536     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.607358     Document Type: Editorial

References (22)

1. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8:1218-1226.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002;91:281-291.
4. Laberge MA, Moore KJ, Freeman MW. Atherosclerosis and innate immune signaling. Ann Med. 2005;37:130-140.
5. Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361-403.
6. Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Horkko S, Miller YI, Woelkers DA, Corr M, Witztum JL. The role of natural antibodies in atherogenesis. J Lipid Res. 2005;46:1353-1363.
7. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol. 1997;5:275-280.
8. Tobias P, Curtiss LK. The immune system and atherogenesis: paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res. 2005;46:404-411.
9. Hajishengallis G, Sharma A, Russell MW, Genco RJ. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis. Ann Periodontol. 2002;7:72-78.
10. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA, Garcia-Cardena G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116:49-58.
11. Nieto FJ. Infective agents and cardiovascular disease. Semin Vasc Med. 2002;2:401-415.
12. Epstein SF, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20-e28.
13. Bruggeman CA. Does cytomegalovirus play a role in atherosclerosis? Herpes. 2000;7:51-54.
14. Dobrilovic N, Vadlamani L, Meyer M, Wright CB. Chlamydia pneumoniae in atherosclerotic carotid artery plaques: high prevalence among heavy smokers. Am Surg. 2001;67:589-593.
15. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144-2148.
16. Muller BT, Huber R, Henrich B, Adams O, Berns G, Siebler M, Jander S, Muller W, Loncar R, Godehardt E, Sandmann W. Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis: does infection influence plaque stability? Vasa. 2005;34:163-169.
17. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kühbacher T, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Günther R, Krüger D, Lins M, Herrmann G, Fölsch UR, Simon R, Schreiber S. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation. 2006;113:929-937.
18. Shannon RP, Simon MA, Mathier MA, Geng YJ, Mankad S, Lackner AA. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation. 2000;101:185-193.
19. Shannon RP. SIV cardiomyopathy in non-human primates. Trends Cardiovasc Med. 2001;11:242-246.
20. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-193.
21. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J. 2000;46:S47-S52.
22. Shiau AL, Wu CL. The inhibitory effect of Staphylococcus epidermidis slime on the phagocytosis of murine peritoneal macrophages is interferon-independent. Microbiol Immunol. 1998;42:33-40.